7ZL Stock Overview
Operates as a health care real estate company in North America. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Invesque Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.068 |
52 Week High | CA$0.21 |
52 Week Low | CA$0.058 |
Beta | 1.46 |
1 Month Change | -4.52% |
3 Month Change | -27.31% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -61.55% |
Recent News & Updates
Recent updates
Shareholder Returns
7ZL | DE Real Estate | DE Market | |
---|---|---|---|
7D | -5.1% | -4.1% | 1.2% |
1Y | n/a | 1.8% | 10.1% |
Return vs Industry: Insufficient data to determine how 7ZL performed against the German Real Estate industry.
Return vs Market: Insufficient data to determine how 7ZL performed against the German Market.
Price Volatility
7ZL volatility | |
---|---|
7ZL Average Weekly Movement | 20.5% |
Real Estate Industry Average Movement | 4.7% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.5% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7ZL's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 7ZL's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 1,766 | Adlai Chester | invesque.com |
Invesque Inc. operates as a health care real estate company in North America. The company's investment property portfolio includes investments in independent living, assisted living, memory care, skilled nursing, and transitional care properties. It also includes investments in owner occupied seniors housing properties, including the ownership of real estate properties, as well as provides management services.
Invesque Inc. Fundamentals Summary
7ZL fundamental statistics | |
---|---|
Market cap | €71.08m |
Earnings (TTM) | -€60.37m |
Revenue (TTM) | €172.46m |
0.4x
P/S Ratio-1.2x
P/E RatioIs 7ZL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
7ZL income statement (TTM) | |
---|---|
Revenue | US$176.68m |
Cost of Revenue | US$121.62m |
Gross Profit | US$55.07m |
Other Expenses | US$116.91m |
Earnings | -US$61.85m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.068 |
Gross Margin | 31.17% |
Net Profit Margin | -35.01% |
Debt/Equity Ratio | 408.8% |
How did 7ZL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/10 23:30 |
End of Day Share Price | 2025/01/10 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Invesque Inc. is covered by 10 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jenny Ma | BMO Capital Markets Equity Research |
Mark Rothschild | Canaccord Genuity |
Chris Couprie | CIBC Capital Markets |